Buy or Sell: Dr Reddy Share Price Target 2023, 2025, 2030 to 2050

Today, we’re going on a journey to explore the estimated Dr Reddy Share Price Target for the years 2023 to 2050. We will use our Research and the company’s growth prospects to make a prediction. By the end of our journey, you will have a better understanding of the expected Dr Reddy Share Price Target.

As an investor or a beginner interested in Dr Reddy, it is essential to understand the potential of Dr Reddy’s share price prediction. We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Dr Reddy Share price target for 2023, 2025, 2030 to 2050.

Additionally, we will also take into account analyst recommendations from various brokerage firms, including target high price, target low price, mean recommendation, and key recommendation.

Dr Reddy Share Price Target

Overview of Dr Reddy


NameDr Reddy’s Laboratories
IndustryPharmaceuticals
TypePublic
Founded1984
CEOGautam Reddy
HeadquartersHyderabad, India
ServicesDrug discovery
development
manufacturing
CountryIndia
LocationsOver 60 countries
Websitedrreddys.com
Profile Dr._Reddy

Keep an eye on Dr Reddy’s share price today with real-time updates, and examine its performance on the stock market through comprehensive charts that display the fluctuations in Dr Reddy’s share price.

Dr Reddy Share Price Live


Fundamentals of Dr Reddy


The fundamental analysis of Dr Reddy Limited focuses on key factors to better understand the company’s valuation. Various valuation techniques have been used, including the Price-to-Earnings Ratio (P/E), Price-to-Sales Ratio (P/S), Price-to-Book Value Ratio (P/B), Dividend Yield, and other Details.

Dr. Reddy’s Laboratories Ltd. is a multinational pharmaceutical company based in India. The company was founded in 1984 and has since grown to become one of the largest pharmaceutical companies in India.

Dr. Reddy’s Laboratories Ltd. specializes in the development, manufacture, and marketing of a wide range of pharmaceutical products, including generic drugs, active pharmaceutical ingredients (APIs), and proprietary products.

The company operates in over 20 countries worldwide and has a strong presence in the United States, India, and Europe. Dr. Reddy’s Laboratories Ltd. is committed to providing affordable and innovative healthcare solutions to patients around the world.

  • Promoters: 26.70%
  • Mutual Funds: 9.87%
  • Foreign Institutions: 27.25%
  • Retail And Others: 23.17%
  • Other Domestic Institutions: 13.01%
CompetitorMarket Share
Sun Pharma14.4%
Lupin13.2%
Aurobindo Pharma11.7%
Cipla10.4%
Glenmark Pharmaceuticals7.6%
Cadila Healthcare6.7%
Torrent Pharmaceuticals5.8%
Dr. Reddy’s Laboratories5.4%

Brokerage Firms

Dr Reddy Share Price Target 2023

An effective method for evaluating the Dr Reddy share price Target is by examining research reports and analyses conducted by reputable financial institutions and brokerage firms.

DATEAUTHORTARGETTYPE
04 JUL 2023Sharekhan5963.00
 Buy
23 JUN 2023Motilal Oswal4680.00
 Neutral
12 MAY 2023KRChoksey5155.00
 Buy
11 MAY 2023BOB Capital Markets Ltd.4900.00
 Hold
11 MAY 2023ICICI Direct5520.00
 Buy
11 MAY 2023Motilal Oswal4500.00
 Neutral
11 MAY 2023Axis Direct5100.00
 Hold
11 MAY 2023Prabhudas Lilladhar4500.00
 Sell
07 FEB 2023Geojit BNP Paribas5166.00
 Buy
27 JAN 2023ICICI Direct5210.00
 Buy
27 JAN 2023Axis Direct5100.00
 Buy
27 JAN 2023ICICI Securities Limited5131.00
 Buy
26 JAN 2023BOB Capital Markets Ltd.4700.00
 Hold

Dr Reddy Share Price History


Our Recommendation


Telegram Channel👉 Click Here
Facebook Page👉 Click Here

Dr Reddy Share Price Target 2023 to 2050

We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Dr Reddy price target for 2023, 2025 to 2030, based on our Research knowledge and forecasting.

Dr Reddy Share Price Target 2023


Our minimum prediction for Dr Reddy share price target in 2023 is ₹5700. We believe that the company’s strong product pipeline and business conditions will continue to drive growth in the coming years. Dr. Reddy’s Laboratories Ltd. has a healthy balance sheet and a strong ROE of 17.5%, which is a testament to the company’s financial stability.

Additionally, the company recently announced its foray into the trade generics business in India, which is expected to drive volume growth and overall revenue growth marginally higher over FY2023-FY2025E. These factors, combined with the company’s attractive valuation of ~18.1x/~17.1x its revised FY2024E/FY2025E EPS estimates, make us confident in our minimum target of ₹5700.

Our maximum prediction for Dr Reddy share price target in 2023 is ₹6200. We believe that the company’s strong product pipeline and business conditions will continue to drive growth in the coming years. Dr. Reddy’s Laboratories Ltd. has a strong presence in the United States, India, and Europe, which gives the company a wide reach and a diverse customer base.

Additionally, the company’s commitment to providing affordable and innovative healthcare solutions to patients around the world is a testament to its long-term growth potential. These factors, combined with the company’s attractive valuation of ~18.1x/~17.1x its revised FY2024E/FY2025E EPS estimates, make us confident in our maximum target of ₹6200.

Dr Reddy Share Price Target 2024


For 2024, we estimate a minimum target of ₹6200 and a maximum target of ₹6700. We believe that the company’s strong product pipeline and business conditions will continue to drive growth in the coming years, and that the company’s commitment to providing affordable and innovative healthcare solutions to patients around the world will be a key driver of its long-term success. Additionally, the company’s recent foray into the trade generics business in India is expected to drive volume growth and overall revenue growth marginally higher over FY2023-FY2025E.

Dr Reddy Share Price Target 2025


Looking ahead to 2025, we estimate a minimum target of ₹7000 and a maximum target of ₹7500. We believe that the company’s strong product pipeline and business conditions will continue to drive growth in the coming years, and that the company’s commitment to providing affordable and innovative healthcare solutions to patients around the world will be a key driver of its long-term success.

Additionally, the company’s recent for ay into the trade generics business in India is expected to drive volume growth and overall revenue growth marginally higher over FY2023-FY2025E. Furthermore, the company’s focus on complex generics and first-to-market products is expected to drive profitable growth in North America over the short to long term.

Dr Reddy Share Price Target 2027


Looking ahead to 2027, we estimate a minimum target of ₹9000 and a maximum target of ₹9500. We believe that the company’s strong product pipeline and business conditions will continue to drive growth in the coming years, and that the company’s commitment to providing affordable and innovative healthcare solutions to patients around the world will be a key driver of its long-term success. Additionally, the company’s focus on complex generics and first-to-market products is expected to drive profitable growth in North America over the short to long term.

Dr Reddy Share Price Target 2030


Looking further ahead, we estimate a minimum target of ₹8000 and a maximum target of ₹10,000 for 2030. By this time, we believe that the company’s strong product pipeline and business conditions will continue to drive growth, and that the company’s commitment to providing affordable and innovative healthcare solutions to patients around the world will be a key driver of its long-term success. Additionally, the company’s focus on complex generics and first-to-market products is expected to drive profitable growth in North America over the short to long term.

Dr Reddy Share Price Target 2050


Looking even further ahead, we estimate a minimum target of ₹15,000 and a maximum target of ₹20,000 for 2040, and a minimum target of ₹25,000 and a maximum target of ₹30,000 for 2050.

These targets are based on our analysis of the company’s financial performance and growth prospects and are subject to change based on a wide range of variables and uncertainties. However, we believe that Dr. Reddy’s Laboratories Ltd. has a strong foundation and a clear strategy for growth, which should enable it to continue delivering value to its shareholders over the long term.

Dr Reddy Share Price Target 2023 to 2050

YearsMinimum TargetMaximum Target
2023₹5700₹6200
2024₹6200₹6700
2025₹7000₹7500
2026₹8000₹8500
2027₹9000₹9500
2030₹8000₹10,000
2040₹15,000₹20,000
2050₹25,000₹30,000

Dr Reddy Share Price Target 2023?

Based on our analysis, the maximum share price target for Dr Reddy in 2023 could be ₹6200.

Dr Reddy Share Price Target 2025?

Based on our analysis, the maximum share price target for Dr Reddy in 2025 could be ₹7500.

Dr Reddy Share Price Target 2030?

Based on our analysis, the maximum share price target for Dr Reddy in 2030 could be ₹10,000.

To stay updated with the latest information related to the stock market and receive live stock market updates, follow Sharedhan and stay connected with us.

Google NewsFacebook
TelegramYoutube

I would like to remind you that I am not authorized by SEBI to provide any financial advice or recommendations. As you know, Share price prediction is not an exact science, That’s why I am conducting in-depth research and using different AI tools to predict share prices. My purpose is only educational, and I am using AI to see what the future of the stock might look like.

Disclaimer– That these Share Price Targets for “Dr Reddy Share Price Target” is only provided for informational purposes only. It does not constitute a recommendation to buy, sell or hold Dr Reddy stock. Investors should conduct their own research and analysis and consult with financial experts before making any investment decisions— Sharedhan.com

3.9/5
Harry
Harry

In 2015, I Started Working as a Blogger Now I am a Versatile Professional With Experience in Blogging and Content Writing. I entered the stock market as a beginner in 2017. I was passionate about the stock market and learned something new every day. I Conduct Thorough Research and Produce High-Quality Content for Our Readers. Every Piece of Content Is Based on My Extensive Expertise and In-Depth Research.

Sharedhan
Logo